BNP Paribas Exane lowers Veeva Systems stock price target on CRM outlook

Switching CRM vendors doesn't fix the underlying problem. It just resets the clock.

Veeva Systems quietly revised its own expectations this week. Management cut its projected CRM wins against Salesforce from 14 deals down to a majority of just four. An analyst at BNP Paribas Exane noticed, lowered the price target, and moved on. But the real story isn't about Veeva's stock.

It's about what happens when a vendor's growth story runs into the reality of how hard it actually is to displace an entrenched CRM — even when customers are unhappy with what they have.

If you're in mid-market ops or marketing, you've lived this from the other side. You know a platform's sales team will tell you anything to win the deal. Then the implementation drags, the customization costs pile up, and 18 months later you're managing the same workarounds in a different interface. The vendor's internal numbers just confirmed what you already suspected: CRM transitions are harder and messier than anyone advertises.

The lesson here isn't that Veeva is failing. It's that the entire model — big vendor, big promise, big switchover — has a built-in failure rate that nobody puts in the contract.

A system that fits your business from day one beats a migration roadmap every time.

#CRM #SalesOps #MarketingOps #MidMarket #BusinessOperations

Original Source

Management reduced its initial expectation for CRM wins versus Salesforce to a majority of four remaining deals from 14 previously. BNP Paribas ...